Esophageal Cancers: Changing Character, Increasing Incidence

doi:10.1093/jnci/91.6.497

JNCI Journal of the National Cancer Institute 1999 91(6):497-498; doi:10.1093/jnci/91.6.497
© 1999 by Oxford University Press

This Article

	Full Text
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Personal Archive
	Download to citation manager
	Request Permissions

Google Scholar

	Articles by McCann, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by McCann, J.

Social Bookmarking

	What's this?

Journal of the National Cancer Institute, Vol. 91, No. 6, 497-498, March 17, 1999
© 1999 Oxford University Press

NEWS

Esophageal Cancers: Changing Character, Increasing Incidence

Jean McCann

Both the character of esophageal cancer and its treatment appearto be changing, although the outlook for long-term survivalfrom this disease, which is usually diagnosed late, remainsgrim, according to investigators at the recent 9th InternationalCongress on Anti-Cancer Treatment in Paris.

Five-year survival is at best only about 30%, the investigatorssaid, although this is an improvement upon the 5% 5-year survivalscommonly seen before combined chemotherapy/radiotherapy trialsbegan about 20 years ago.

The common histology of the tumor also appears to be changingfrom squamous . . . [Full Text of this Article]

Reflux Link

Prevention Is Key

Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us What's this?

This article has been cited by other articles:

V. P. Rao, T. Poutahidis, Z. Ge, P. R. Nambiar, C. Boussahmain, Y. Y. Wang, B. H. Horwitz, J. G. Fox, and S. E. Erdman
Innate Immune Inflammatory Response against Enteric Bacteria Helicobacter hepaticus Induces Mammary Adenocarcinoma in Mice.
Cancer Res., August 1, 2006; 66(15): 7395 - 7400.
[Abstract] [Full Text] [PDF]

D. Il'yasova, L. H. Colbert, T. B. Harris, A. B. Newman, D. C. Bauer, S. Satterfield, and S. B. Kritchevsky
Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2413 - 2418.
[Abstract] [Full Text] [PDF]

X.-c. Xu, J. J. Lee, T.-T. Wu, A. Hoque, J. A. Ajani, and S. M. Lippman
Increased Retinoic Acid Receptor-{beta}4 Correlates In vivo with Reduced Retinoic Acid Receptor-{beta}2 in Esophageal Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 826 - 829.
[Abstract] [Full Text] [PDF]

A. Hoque, S. M. Lippman, T.-T. Wu, Y. Xu, Z. D. Liang, S. Swisher, H. Zhang, L. Cao, J. A. Ajani, and X.-c. Xu
Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention
Carcinogenesis, April 1, 2005; 26(4): 785 - 791.
[Abstract] [Full Text] [PDF]

S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, J. de Oca, G. Capella, and F. Canzian
Association of Common Polymorphisms in Inflammatory Genes Interleukin (IL)6, IL8, Tumor Necrosis Factor {alpha}, NFKB1, and Peroxisome Proliferator-activated Receptor {gamma} with Colorectal Cancer ,
Cancer Res., July 1, 2003; 63(13): 3560 - 3566.
[Abstract] [Full Text] [PDF]

Z. Liang, S. M. Lippman, A. Kawabe, Y. Shimada, and X.-c. Xu
Identification of Benzo(a)pyrene Diol Epoxide-binding DNA Fragments Using DNA Immunoprecipitation Technique
Cancer Res., April 1, 2003; 63(7): 1470 - 1474.
[Abstract] [Full Text] [PDF]

M. Li, R. Lotan, B. Levin, E. Tahara, S. M. Lippman, and X.-C. Xu
Aspirin Induction of Apoptosis in Esophageal Cancer: A Potential for Chemoprevention
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 545 - 549.
[Abstract] [Full Text]

				D. Il'yasova, L. H. Colbert, T. B. Harris, A. B. Newman, D. C. Bauer, S. Satterfield, and S. B. Kritchevsky Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2413 - 2418. [Abstract] [Full Text] [PDF]

				X.-c. Xu, J. J. Lee, T.-T. Wu, A. Hoque, J. A. Ajani, and S. M. Lippman Increased Retinoic Acid Receptor-{beta}4 Correlates In vivo with Reduced Retinoic Acid Receptor-{beta}2 in Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 826 - 829. [Abstract] [Full Text] [PDF]

				A. Hoque, S. M. Lippman, T.-T. Wu, Y. Xu, Z. D. Liang, S. Swisher, H. Zhang, L. Cao, J. A. Ajani, and X.-c. Xu Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention Carcinogenesis, April 1, 2005; 26(4): 785 - 791. [Abstract] [Full Text] [PDF]

				S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, J. de Oca, G. Capella, and F. Canzian Association of Common Polymorphisms in Inflammatory Genes Interleukin (IL)6, IL8, Tumor Necrosis Factor {alpha}, NFKB1, and Peroxisome Proliferator-activated Receptor {gamma} with Colorectal Cancer , Cancer Res., July 1, 2003; 63(13): 3560 - 3566. [Abstract] [Full Text] [PDF]

				Z. Liang, S. M. Lippman, A. Kawabe, Y. Shimada, and X.-c. Xu Identification of Benzo(a)pyrene Diol Epoxide-binding DNA Fragments Using DNA Immunoprecipitation Technique Cancer Res., April 1, 2003; 63(7): 1470 - 1474. [Abstract] [Full Text] [PDF]

				M. Li, R. Lotan, B. Levin, E. Tahara, S. M. Lippman, and X.-C. Xu Aspirin Induction of Apoptosis in Esophageal Cancer: A Potential for Chemoprevention Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 545 - 549. [Abstract] [Full Text]